TransMedics Group's CEO is Waleed Hassanein, appointed in Aug 1998, has a tenure of 27.92 years. total yearly compensation is $10.92M, comprised of 7.1% salary and 92.9% bonuses, including company stock and options. directly owns 1.63% of the company’s shares, worth €37.60M. The average tenure of the management team and the board of directors is 3.5 years and 12.7 years respectively.
Key information
Waleed Hassanein
Chief executive officer
US$10.9m
Total compensation
CEO salary percentage
7.12%
CEO tenure
27.9yrs
CEO ownership
1.6%
Management average tenure
3.5yrs
Board average tenure
12.7yrs
Recent management updates
Recent updates
CEO Compensation Analysis
How has Waleed Hassanein's remuneration changed compared to TransMedics Group's earnings?
Date
Total Compensation
Salary
Company Earnings
Mar 31 2026
n/a
n/a
US$172m
Dec 31 2025
US$11m
US$777k
US$190m
Sep 30 2025
n/a
n/a
US$92m
Jun 30 2025
n/a
n/a
US$72m
Mar 31 2025
n/a
n/a
US$49m
Dec 31 2024
US$8m
US$688k
US$35m
Sep 30 2024
n/a
n/a
US$33m
Jun 30 2024
n/a
n/a
US$3m
Mar 31 2024
n/a
n/a
-US$10m
Dec 31 2023
US$7m
US$634k
-US$25m
Sep 30 2023
n/a
n/a
-US$36m
Jun 30 2023
n/a
n/a
-US$18m
Mar 31 2023
n/a
n/a
-US$28m
Dec 31 2022
US$3m
US$575k
-US$36m
Sep 30 2022
n/a
n/a
-US$42m
Jun 30 2022
n/a
n/a
-US$48m
Mar 31 2022
n/a
n/a
-US$47m
Dec 31 2021
US$7m
US$535k
-US$44m
Sep 30 2021
n/a
n/a
-US$38m
Jun 30 2021
n/a
n/a
-US$30m
Mar 31 2021
n/a
n/a
-US$28m
Dec 31 2020
US$2m
US$534k
-US$29m
Sep 30 2020
n/a
n/a
-US$32m
Jun 30 2020
n/a
n/a
-US$35m
Mar 31 2020
n/a
n/a
-US$36m
Dec 28 2019
US$3m
US$449k
-US$34m
Compensation vs Market: Waleed's total compensation ($USD10.92M) is above average for companies of similar size in the Italian market ($USD4.25M).
Compensation vs Earnings: Waleed's compensation has increased by more than 20% in the past year.
CEO
Waleed Hassanein (58 yo)
27.9yrs
Tenure
US$10,915,533
Compensation
Dr. Waleed H. Hassanein, M.D., is the Founder of Transmedics Group, Inc. and has been its President, Chief Executive Officer and Director since August 1998. He founded TransMedics, Inc. in August 1998 and...
Leadership Team
Name
Position
Tenure
Compensation
Ownership
Waleed Hassanein
Founder
27.9yrs
US$10.92m
1.63% € 37.6m
Gerardo Hernandez
CFO & Treasurer
1.6yrs
US$1.57m
0.0087% € 199.4k
Nicholas Corcoran
Senior Vice President of Supply Chain & Operations
3.5yrs
US$2.82m
0.042% € 955.8k
Tamer Khayal
Senior Vice President of International
20.5yrs
US$3.75m
0.044% € 1.0m
Anil Ranganath
Advisor
less than a year
US$1.50m
0.013% € 305.1k
Matthew Forsyth
Senior VP
less than a year
no data
no data
Miriam Provost
Vice President of Global Regulatory Affairs
7.1yrs
US$813.47k
no data
3.5yrs
Average Tenure
56yo
Average Age
Experienced Management: 1TMDX's management team is considered experienced (3.5 years average tenure).
Board Members
Name
Position
Tenure
Compensation
Ownership
Waleed Hassanein
Founder
27.9yrs
US$10.92m
1.63% € 37.6m
Edwin Kania
Independent Director
22.6yrs
US$328.21k
0.89% € 20.5m
Merilee Raines
Independent Director
5.5yrs
US$354.17k
0.012% € 270.3k
James Tobin
Independent Chairman
15yrs
US$399.21k
0.51% € 11.8m
Edward Zavala
Member of Advisory Board
no data
no data
no data
Gayle Winters
Member of Advisory Board
no data
no data
no data
Ryszard Smolenski
Member of Advisory Board
no data
no data
no data
Bruce Rosengard
Member of Advisory Board
no data
no data
no data
Scott D. Solomon
Member of Advisory Board
no data
no data
no data
Robert Kormos
Member of Advisory Board
no data
no data
no data
Edward Basile
Independent Director
10.4yrs
US$345.05k
0.0083% € 190.9k
Thomas Gunderson
Independent Director
9.9yrs
US$354.77k
0.040% € 914.1k
12.7yrs
Average Tenure
72.5yo
Average Age
Experienced Board: 1TMDX's board of directors are seasoned and experienced ( 12.7 years average tenure).
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/07/29 16:23
End of Day Share Price
2026/07/29 00:00
Earnings
2026/03/31
Annual Earnings
2025/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
TransMedics Group, Inc. is covered by 15 analysts. 13 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.